Cargando…

Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic

IMPORTANCE: Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalizations. OBJECTIVE: To describe the epidemiology and burden of RSV-associated hospitalizations among children and adolescents in Canadian tertiary pediatric hospitals from 2017 to 2022, including changes during th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourdeau, Malou, Vadlamudi, Nirma Khatri, Bastien, Nathalie, Embree, Joanne, Halperin, Scott A., Jadavji, Taj, Kazmi, Kescha, Langley, Joanne M., Lebel, Marc H., Le Saux, Nicole, Moore, Dorothy, Morris, Shaun K., Pernica, Jeffrey M., Robinson, Joan, Sadarangani, Manish, Bettinger, Julie A., Papenburg, Jesse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551765/ https://www.ncbi.nlm.nih.gov/pubmed/37792376 http://dx.doi.org/10.1001/jamanetworkopen.2023.36863

Ejemplares similares

2613. Pediatric respiratory syncytial virus hospitalizations, 2017 to 2022, the Canadian Immunization Monitoring Program Active (IMPACT)
por: Bourdeau, Malou, et al.
Publicado: (2023)

Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018
por: Alsager, Khaled, et al.
Publicado: (2022)

Strategies to Prevent Early and Late-Onset Group B Streptococcal Infection via Interventions in Pregnancy
por: Delara, Mahin, et al.
Publicado: (2023)

Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network
por: Murad, Yousif, et al.
Publicado: (2022)

1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children
por: Groves, Helen E, et al.
Publicado: (2021)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based study
por: Groves, Helen E., et al.
Publicado: (2021)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study
por: Papenburg, Jesse, et al.
Publicado: (2020)

Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults
por: Marra, Fawziah, et al.
Publicado: (2019)

Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
por: Lau, Oscar, et al.
Publicado: (2022)

Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada
por: Nourbakhsh, Shokoofeh, et al.
Publicado: (2021)

Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals
por: McDermid, Andrew, et al.
Publicado: (2012)

Could COVID-19 Reverse the Modest Gains Made in Newborn Health in Ethiopia?
por: Estifanos, Abiy Seifu, et al.
Publicado: (2021)

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials
por: Manca, Terra A., et al.
Publicado: (2022)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

1462. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis
por: Marra, Fawziah, et al.
Publicado: (2020)

1397. Long term impact of the 13-valent pneumococcal conjugate vaccine use in infant immunization program on all-cause pneumonia hospitalizations in British Columbia, Canada: a time series analysis
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

Risk Factors for Herpes Zoster Infection: A Meta-Analysis
por: Marra, Fawziah, et al.
Publicado: (2020)

Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network
por: Suresh, Sneha, et al.
Publicado: (2022)

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal()
por: Chu, Helen Y., et al.
Publicado: (2017)

Meeting Report: Harmonization of RSV therapeutics – from design to performance
por: Nair, Harish, et al.
Publicado: (2016)

2706. Indirect Effects of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Adults in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

2701. The Impact of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Children in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

2705. Serotype Replacement Following Childhood Pneumococcal Conjugate Vaccination Programs in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

1936. Efficacy of One Dose of the Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Adults ≥ 60 Years of Age Persists for 2 RSV Seasons
por: Ison, Michael G, et al.
Publicado: (2023)

2302. A Meta-Analysis of Risk Factors for Herpes Zoster Infection
por: Parhar, Kamalpreet K, et al.
Publicado: (2019)

Against vaccine assay secrecy
por: Herder, Matthew, et al.
Publicado: (2015)

Peritoneal dialysis-related peritonitis caused by Gordonia bronchialis: first pediatric report
por: Bruno, Valentina, et al.
Publicado: (2021)

Correction to: Peritoneal dialysis-related peritonitis caused by Gordonia bronchialis: first pediatric report
por: Bruno, Valentina, et al.
Publicado: (2022)

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age
por: Díez-Domingo, Javier, et al.
Publicado: (2022)

Meterology-driven Prediction of RSV/RHV Incidence in Rural Nepal
por: Scott, Anna, et al.
Publicado: (2017)

Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups
por: Rafferty, Ellen, et al.
Publicado: (2022)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020
por: Drouin, Olivier, et al.
Publicado: (2021)

Caractéristiques des hospitalisations au Canada d’enfants ayant contracté une infection aiguë par le SRAS-CoV-2 en 2020
por: Drouin, Olivier, et al.
Publicado: (2021)

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants
por: Rainisch, Gabriel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k9gf8g9io5i4bkcm2peggqs2gf